Hostname: page-component-7dd5485656-zklqj Total loading time: 0 Render date: 2025-10-22T05:10:27.713Z Has data issue: false hasContentIssue false
  • English
  • Français

Reviewer Comment on Halabi et al. “Safety and Real-World Effectiveness in the Transition from Alteplase to Tenecteplase for Stroke Treatment”

Published online by Cambridge University Press:  21 May 2025

Alex S. Trussell  and
Philip M.C. Choi Open the ORCID record for Philip M.C. Choi [Opens in a new window]
Alex S. Trussell
Affiliation:
Department of Neuroscience, Eastern Health, Melbourne, Victoria, Australia Eastern Health Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia
Philip M.C. Choi*
Affiliation:
Department of Neuroscience, Eastern Health, Melbourne, Victoria, Australia Eastern Health Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia
*
Corresponding author: Philip M.C. Choi; Email: philip.choi@monash.edu
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Information

Type
Reviewer Comment
Information
Canadian Journal of Neurological Sciences , First View , pp. 1
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of Canadian Neurological Sciences Federation

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Halabi, ML, et al. Safety and real-world effectiveness in the transition from Alteplase to Tenecteplase for stroke treatment. Can J Neurol Sci [Preprint]. 2025.10.1017/cjn.2025.10121CrossRefGoogle ScholarPubMed
Ray, B, Janzen, KM, Curran, M, et al. Comparison of dosing errors between tenecteplase and alteplase for management of acute ischemic stroke. J Am Pharm Assn. 2022;0:643–647. DOI: 10.1016/j.japh.2022.10.015.Google Scholar
Kobayashi, Y, Saito, T, Kawabata, Y, et al. A 5-minute delay from bolus injection to infusion halves plasma concentration of tissue plasminogen activator. J Emerg Med. 2023;64:709–713. DOI: 10.1016/j.jemermed.2023.03.059.10.1016/j.jemermed.2023.03.059CrossRefGoogle ScholarPubMed
Kamal, N, Jeerakathil, T, Stang, J, et al. Provincial door-to-needle improvement initiative results in improved patient outcomes across an entire population. Stroke. 2020;51:2339–2346. DOI: 10.1161/strokeaha.120.029734.10.1161/STROKEAHA.120.029734CrossRefGoogle ScholarPubMed